Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99

1.

Efficacy of recombinant human C1 esterase inhibitor across anatomic locations in acute hereditary angioedema attacks.

Baker JW, Bernstein JA, Harper JR, Relan A, Riedl MA.

Allergy Asthma Proc. 2018 Sep 28;39(5):359-364. doi: 10.2500/aap.2018.39.4151. Epub 2018 Jun 28.

PMID:
29954477
2.

Design of a sustainable prepolarizing magnetic resonance imaging system for infant hydrocephalus.

Obungoloch J, Harper JR, Consevage S, Savukov IM, Neuberger T, Tadigadapa S, Schiff SJ.

MAGMA. 2018 Oct;31(5):665-676. doi: 10.1007/s10334-018-0683-y. Epub 2018 Apr 11.

3.

C1 esterase inhibitor concentrates and attenuated androgens - Authors' reply.

Riedl MA, Relan A, Harper JR, Cicardi M.

Lancet. 2018 Apr 7;391(10128):1356. doi: 10.1016/S0140-6736(18)30573-7. No abstract available.

PMID:
29636270
4.

Recombinant human C1 esterase inhibitor for acute hereditary angioedema attacks with upper airway involvement.

Riedl MA, Li HH, Cicardi M, Harper JR, Relan A.

Allergy Asthma Proc. 2017 Nov 13;38(6):462-466. doi: 10.2500/aap.2017.38.4090. Epub 2017 Sep 13.

PMID:
28903805
5.

Efficacy of recombinant human C1 esterase inhibitor for the treatment of severe hereditary angioedema attacks.

Li HH, Reshef A, Baker JW, Harper JR, Relan A.

Allergy Asthma Proc. 2017 Nov 5;38(6):456-461. doi: 10.2500/aap.2017.38.4088. Epub 2017 Sep 5.

PMID:
28874235
6.
7.

Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trial.

Riedl MA, Grivcheva-Panovska V, Moldovan D, Baker J, Yang WH, Giannetti BM, Reshef A, Andrejevic S, Lockey RF, Hakl R, Kivity S, Harper JR, Relan A, Cicardi M.

Lancet. 2017 Sep 30;390(10102):1595-1602. doi: 10.1016/S0140-6736(17)31963-3. Epub 2017 Jul 25.

PMID:
28754491
8.

Sustained response of recombinant human C1 esterase inhibitor for acute treatment of hereditary angioedema attacks.

Bernstein JA, Relan A, Harper JR, Riedl M.

Ann Allergy Asthma Immunol. 2017 Apr;118(4):452-455. doi: 10.1016/j.anai.2017.01.029. Epub 2017 Mar 9.

9.

Recombinant Human C1-Esterase Inhibitor to Treat Acute Hereditary Angioedema Attacks in Adolescents.

Baker JW, Reshef A, Moldovan D, Harper JR, Relan A, Riedl MA.

J Allergy Clin Immunol Pract. 2017 Jul - Aug;5(4):1091-1097. doi: 10.1016/j.jaip.2016.11.005. Epub 2017 Feb 13.

10.

Randomized, Double-Blind Trial of Oral Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Chronic Noncancer Pain.

Rauck R, Slatkin NE, Stambler N, Harper JR, Israel RJ.

Pain Pract. 2017 Jul;17(6):820-828. doi: 10.1111/papr.12535. Epub 2017 Feb 10.

PMID:
27860208
11.

Baseline Oral 5-ASA Use and Efficacy and Safety of Budesonide Foam in Patients with Ulcerative Proctitis and Ulcerative Proctosigmoiditis: Analysis of 2 Phase 3 Studies.

Bosworth BP, Sandborn WJ, Rubin DT, Harper JR.

Inflamm Bowel Dis. 2016 Aug;22(8):1881-6. doi: 10.1097/MIB.0000000000000860.

12.

An Automated and Minimally Invasive Tool for Generating Autologous Viable Epidermal Micrografts.

Osborne SN, Schmidt MA, Harper JR.

Adv Skin Wound Care. 2016 Feb;29(2):57-64. doi: 10.1097/01.ASW.0000476072.88818.aa.

13.
14.

Is there a role for pharmacoeconomics in developing countries?

Harper JR.

Pharmacoeconomics. 2011 May;29(5):435-6; author reply 436-7. doi: 10.2165/11585770-000000000-00000. No abstract available.

PMID:
21504243
15.

I've arrived in cyberspace, have you seen my lecture?

Burke MS, Harper JR.

Nurse Educ. 2010 May-Jun;35(3):101-2. doi: 10.1097/NNE.0b013e3181d95056. No abstract available.

PMID:
20410742
16.

The use of acellular dermal matrix to prevent capsule formation around implants in a primate model.

Stump A, Holton LH 3rd, Connor J, Harper JR, Slezak S, Silverman RP.

Plast Reconstr Surg. 2009 Jul;124(1):82-91. doi: 10.1097/PRS.0b013e3181ab112d.

PMID:
19568048
17.

A porcine-derived acellular dermal scaffold that supports soft tissue regeneration: removal of terminal galactose-alpha-(1,3)-galactose and retention of matrix structure.

Xu H, Wan H, Zuo W, Sun W, Owens RT, Harper JR, Ayares DL, McQuillan DJ.

Tissue Eng Part A. 2009 Jul;15(7):1807-19. doi: 10.1089/ten.tea.2008.0384.

PMID:
19196142
18.

Host response to implanted porcine-derived biologic materials in a primate model of abdominal wall repair.

Sandor M, Xu H, Connor J, Lombardi J, Harper JR, Silverman RP, McQuillan DJ.

Tissue Eng Part A. 2008 Dec;14(12):2021-31. doi: 10.1089/ten.tea.2007.0317.

PMID:
18657025
19.

Host response to human acellular dermal matrix transplantation in a primate model of abdominal wall repair.

Xu H, Wan H, Sandor M, Qi S, Ervin F, Harper JR, Silverman RP, McQuillan DJ.

Tissue Eng Part A. 2008 Dec;14(12):2009-19. doi: 10.1089/ten.tea.2007.0316.

PMID:
18593339
20.
21.

Periplasmic peptidyl prolyl cis-trans isomerases are not essential for viability, but SurA is required for pilus biogenesis in Escherichia coli.

Justice SS, Hunstad DA, Harper JR, Duguay AR, Pinkner JS, Bann J, Frieden C, Silhavy TJ, Hultgren SJ.

J Bacteriol. 2005 Nov;187(22):7680-6.

22.

Improving thromboprophylaxis in elderly patients with non-valvular atrial fibrillation.

Lowdon DW, Harper JR, Gillespie ND.

Scott Med J. 2004 Nov;49(4):148-50.

PMID:
15648711
23.

Institutional falls: quality not quantity.

McMurdo ME, Harper JR.

Age Ageing. 2004 Jul;33(4):399-400. No abstract available.

PMID:
15226106
24.

Falls, bones and the primary care team.

McMurdo ME, Harper JR.

Eur J Gen Pract. 2003 Mar;9(1):10-2.

PMID:
14611008
25.

Preferences for different high-energy foods in elderly medical in-patients.

Harper JR, McAlpine S, Hetherington MM, Bolton-Smith C, McMurdo ME.

Scott Med J. 2001 Dec;46(6):171-2.

PMID:
11852630
26.

Genetic evidence for parallel pathways of chaperone activity in the periplasm of Escherichia coli.

Rizzitello AE, Harper JR, Silhavy TJ.

J Bacteriol. 2001 Dec;183(23):6794-800.

28.

Rediscovering the joy of food: the need for long-term review of swallowing ability in stroke patients.

Harper JR, McMurdo ME, Robinson A.

Scott Med J. 2001 Apr;46(2):54-5.

PMID:
11394341
29.

An old infection: the importance of pulmonary tuberculosis in elderly people in Scotland.

Harper JR.

Scott Med J. 1999 Oct;44(5):134-6. No abstract available.

PMID:
10629907
30.

Racial discrimination in distinction awards. Vested interest prevents true debate.

Harper JR.

BMJ. 1998 Jun 27;316(7149):1978; author reply 1979. No abstract available.

PMID:
9687183
32.

Antifibrotic effect of decorin in a bleomycin hamster model of lung fibrosis.

Giri SN, Hyde DM, Braun RK, Gaarde W, Harper JR, Pierschbacher MD.

Biochem Pharmacol. 1997 Dec 1;54(11):1205-16.

PMID:
9416971
34.

Manipulation of cellular interactions with biomaterials toward a therapeutic outcome: a perspective.

Pierschbacher MD, Polarek JW, Craig WS, Tschopp JF, Sipes NJ, Harper JR.

J Cell Biochem. 1994 Oct;56(2):150-4. Review.

PMID:
7829572
35.

Role of transforming growth factor beta and decorin in controlling fibrosis.

Harper JR, Spiro RC, Gaarde WA, Tamura RN, Pierschbacher MD, Noble NA, Stecker KK, Border WA.

Methods Enzymol. 1994;245:241-54. No abstract available.

PMID:
7760736
36.

Effect of rate on changes in conduction velocity and extracellular potassium concentration during acute ischemia in the in situ pig heart.

Harper JR Jr, Johnson TA, Engle CL, Martin DG, Fleet W, Gettes LS.

J Cardiovasc Electrophysiol. 1993 Dec;4(6):661-71.

PMID:
8305986
37.

Aortic dissection with aortopulmonary artery fistula.

Tate DA, Parker LA, Starek PJ, Harper JR Sr.

Cathet Cardiovasc Diagn. 1993 Jun;29(2):154-6.

PMID:
8348603
38.

Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease.

Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Yu, Pierschbacher MD, Ruoslahti E.

Nature. 1992 Nov 26;360(6402):361-4.

PMID:
1280332
39.

Epidemic of bronchiolitis in infants.

Gibbs T, Harper JR.

BMJ. 1992 Feb 15;304(6824):444. No abstract available.

40.

In vivo interactions of TGF-beta and extracellular matrix.

Noble NA, Harper JR, Border WA.

Prog Growth Factor Res. 1992;4(4):369-82. Review.

PMID:
1340215
41.

Isolation and sequence of partial cDNA clones of human L1: homology of human and rodent L1 in the cytoplasmic region.

Harper JR, Prince JT, Healy PA, Stuart JK, Nauman SJ, Stallcup WB.

J Neurochem. 1991 Mar;56(3):797-804.

PMID:
1993895
42.
43.

Effect of inhibitors of N-linked oligosaccharide processing on the cell surface expression of a melanoma integrin.

Spiro RC, Laufer DM, Perry SK, Harper JR.

J Cell Biochem. 1989 Sep;41(1):37-45.

PMID:
2480355
44.

Efficient surface expression of platelet GPIIb-IIIa requires both subunits.

O'Toole TE, Loftus JC, Plow EF, Glass AA, Harper JR, Ginsberg MH.

Blood. 1989 Jul;74(1):14-8.

PMID:
2752106
45.
46.

Expression of transfected DNA by primary murine keratinocytes.

Harper JR, Greenhalgh DA, Yuspa SH.

J Invest Dermatol. 1988 Aug;91(2):150-3.

47.

Biochemical characterization of a sulfated phosphoglycoprotein antigen expressed on human small cell lung carcinoma.

Koyama Y, Yang HM, Wargalla U, Reisfeld RA, Harper JR.

J Biol Chem. 1988 Jan 15;263(2):806-11.

48.

Paediatric intensive care in a district general hospital.

Evans NJ, Omenaka IL, Harper JR.

Arch Dis Child. 1988 Jan;63(1):31-4.

49.

Analysis of the rasH oncogene and its p21 product in chemically induced skin tumors and tumor-derived cell lines.

Harper JR, Reynolds SH, Greenhalgh DA, Strickland JE, Lacal JC, Yuspa SH.

Carcinogenesis. 1987 Dec;8(12):1821-5.

PMID:
2824083
50.

Antigenic mimicry of a human cellular polypeptide by Mycoplasma hyorhinis.

Fernsten PD, Pekny KW, Harper JR, Walker LE.

Infect Immun. 1987 Jul;55(7):1680-5.

Supplemental Content

Loading ...
Support Center